FDA Recalls Two Dietary Supplements for Containing 'Hidden Drug Ingredients'

The Food and Drug Administration (FDA) recently issued a recall for two dietary supplements, ZoomMax and ZapMax, designed to support men's health. This action was taken after the FDA discovered that these products contained "hidden drug ingredients," posing potential risks to consumers.

ZoomMax and ZapMax are marketed as dietary supplements aimed at enhancing male performance and energy. However, upon investigation, the FDA found undisclosed drug ingredients in these products, prompting concerns about their safety and efficacy.

The FDA expressed its inability to test and identify all products labeled as dietary supplements that may contain harmful hidden ingredients. This warning comes on the heels of increasing instances of tainted supplements being sold to unsuspecting consumers.

In a separate recall alert, the FDA also warned against consuming certain ground cinnamon products due to elevated levels of lead, a toxic metal that can pose serious health risks if ingested. The agency identified 11 brands, including Super Brand, that tested positive for unsafe levels of lead, prompting a call for consumers to discard these products immediately.

Lead contamination in food products is a serious concern as exposure to this heavy metal can lead to various health issues, especially in vulnerable populations such as children and pregnant women. The FDA's vigilance in monitoring and regulating contaminated food products is crucial in safeguarding public health.

Furthermore, recent data from the FDA revealed a significant increase in food recalls, particularly class one recalls that involve products with the highest risk of causing severe illness or even death. This trend underscores the importance of stringent quality control measures and swift regulatory action to prevent harm to consumers.

In another development, the FDA announced a voluntary recall of more than 7000 bottles of duloxetine delayed-release capsules due to unacceptable levels of a potential carcinogen known as nitrosamine impurity. Exposure to this impurity above permissible limits over an extended period may elevate the risk of cancer, necessitating caution among healthcare professionals and patients alike.